Charlotte Caldwell, mother of 12-year-old Billy Caldwell who suffers from severe epilepsy, called the development “incredible.”
”For the first time in months I’m almost lost for words, other than ‘thank-you Sajid Javid.’” — Charlotte Caldwell, via The Independent
Now, the UK‘s Department of Health and Social Care (DHSC) and the Medicines and Healthcare Products Regulatory Authority (MHRA) face the task of providing a clear definition of what constitutes the newly legal cannabis-derived medicinal products. Once that definition is established, those products specifically will be rescheduled and made available via a doctor’s prescription.
Sir Mike Penning, MP and co-chairman of a bipartisan parliamentary group that pushes for cannabis reforms, warned against over-regulating the newly legal products.
“Any move to restrict medical cannabis in the UK to a very narrow range of derived products, each requiring full pharmaceutical trials, thereby blocking out the many products available overseas, will lead to great disappointment and be a missed opportunity.” — MP Mike Penning, co-chairman of parliamentary group Medical Cannabis Under Prescription, in the report.